Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Alessandro, Alonzo"'
Publikováno v:
Monaldi Archives for Chest Disease (2023)
Dear Editor, We thank Dr. Finsterer and Dr. Stollberger for their interest in our published manuscript which is focused on the collected data from patients hospitalized in our multidisciplinary COVID-19 department who experienced a Tako-Tsubo syndrom
Externí odkaz:
https://doaj.org/article/0f05562c8c5e4b6d80fdaaeb88c9145c
Autor:
Alessandro Alonzo, Stefania Angela Di Fusco, Lorenzo Castello, Andrea Matteucci, Antonella Spinelli, Gaetano Marino, Stefano Aquilani, Giuseppe Imperoli, Furio Colivicchi
Publikováno v:
Monaldi Archives for Chest Disease (2023)
Growing evidence shows that COVID-19 is associated with an increase in Tako-Tsubo syndrome (TTS) incidence. We collected data from patients hospitalized in our multidisciplinary COVID-19 department who had a diagnosis of TTS during the second and thi
Externí odkaz:
https://doaj.org/article/09d25f89f5484122ae53d0d0a32df9a6
Autor:
Stefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, Andrea Matteucci, Rita Cristina Myriam Intravaia, Stefano Aquilani, Manlio Cipriani, Leonardo De Luca, Alessandro Navazio, Serafina Valente, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi
Publikováno v:
European Heart Journal Supplements. 25:D278-D286
In the growing therapeutic armamentarium for heart failure (HF) management, vericiguat represents an innovative therapeutic option. The biological target of this drug is different from that of other drugs for HF. Indeed, vericiguat does not inhibit n
Autor:
Stefania Angela, Di Fusco, Cinzia, Cianfrocca, Irma, Bisceglia, Antonella, Spinelli, Alessandro, Alonzo, Edoardo, Mocini, Michele Massimo, Gulizia, Domenico, Gabrielli, Fabrizio, Oliva, Giuseppe, Imperoli, Furio, Colivicchi
Publikováno v:
International Journal of Cardiology. 363:190-195
Emerging evidence demonstrates an intimate interplay between cardiovascular disease and cancer pathophysiology. The aim of this review is to shed light on the common biological pathways underlying cardiovascular disease and cancer. These common pathw
Autor:
Stefania Angela Di Fusco, Stefano Aquilani, Antonella Spinelli, Alessandro Alonzo, Andrea Matteucci, Lorenzo Castello, Giuseppe Imperoli, Furio Colivicchi
Publikováno v:
Progress in Cardiovascular Diseases.
Autor:
Stefania Angela Di Fusco, Marcello Arca, Pietro Scicchitano, Alessandro Alonzo, Francesco Perone, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Giuseppe Imperoli, Furio Colivicchi
Publikováno v:
Heart. 109:18-25
Lipoprotein(a) (Lp(a)) is a complex circulating lipoprotein, and increasing evidence has demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) and as a possible therapeutic target. Lp(a) atherogenic effects are att
Autor:
Carmine Savoia, Lidia Sada, Luigi Zezza, Lorenzo Pucci, Francesco Maria Lauri, Alberto Befani, Alessandro Alonzo, Massimo Volpe
Publikováno v:
International Journal of Hypertension, Vol 2011 (2011)
Essential hypertension is characterized by increased peripheral vascular resistance to blood flow. The endothelium is a crucial regulator of vascular tone. Its function is impaired in patients with hypertension, with reduced vasodilation, increased v
Externí odkaz:
https://doaj.org/article/f9121b5446d94390a11cab0a6965386a
Autor:
Andrea Berni, Francesca Giovannelli, Alessandro Sciahbasi, Alessandro Alonzo, Stefano Rigattieri, Massimo Volpe, Cristian Di Russo
Publikováno v:
Catheterization and Cardiovascular Interventions. 87:849-854
Objectives To compare the incidence of major adverse cardiac and cerebrovascular events (MACCE) and thrombolysis in myocardial infarction (TIMI) bleedings in primary percutaneous coronary intervention (pPCI) performed through transradial approach (TR
Autor:
Andrea Berni, Alessandro Alonzo, Roberto Ricci, Rodrigo Sebik, Alessandro Sciahbasi, Bernardo Cortese, Stefano Rigattieri, Romano Seregni, Maurizio Tespili, Francesca Giovannelli, Pedro Silva-Orrego, Flavia Belloni
Publikováno v:
The American Journal of Cardiology. 114:820-825
The risk of acute kidney injury (AKI) is a major issue after percutaneous coronary interventions (PCIs), especially in the setting of ST-elevation myocardial infarction. Preliminary data from large retrospective registries seem to show a reduction of